Insider Sale by Neervannan Seshadri (Chief Operating Officer)
Trade Summary
6 days ago, Neervannan Seshadri, serving as Chief Operating Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 4,564 shares at $85.00 per share, for a total transaction value of $387,940.00. Following this transaction, Neervannan Seshadri now holds 78,532 shares of TARS.
This sale represents a 5.49% decrease in Neervannan Seshadri's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Friday, September 4, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 4:12 PM ET, 5 days after the trade was made.
Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$85.00
Quantity
4,564
Total Value
$387,940.00
Shares Owned
78,532
Trade Date
6 days ago
SEC Filing Date
at 4:12 PM ET
Filed 5 days after trade
Discussion